Stocks EHLD Financial statements
Financial statementsEuroholdings Ltd. financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Euroholdings Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Revenue | 24.5 | 16.5 | 15.6 | 13.2 |
| General and administrative | 0.8 | 0.78 | 0.82 | 1.5 |
| Operating expenses | 10.2 | 8.54 | 11.8 | -1.46 |
| Operating income | 14.3 | 7.96 | 3.83 | 14.7 |
| Other non-operating income | -0.23 | -0.23 | -0.06 | 0.07 |
| Net income | 14 | 7.73 | 3.77 | 14.8 |
| EBITDA | 15.6 | 9.43 | 3.87 | 15 |
| EPS, diluted | 2.78 | 1.36 | 5.27 | |
| Shares, diluted (weighted) | 2.78 | 2.78 | 2.8 |
Balance sheet
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Cash and equivalents | 0.83 | 0.49 | 0.13 | 3.34 |
| Receivables | 0.52 | 0.44 | 1.83 | |
| Inventory | 0.3 | 0.65 | 0.61 | |
| Other current assets | 0.05 | 0.11 | 0.22 | |
| Total current assets | 2.26 | 2.37 | 7.26 | |
| Property, plant and equipment | 6.88 | 5.97 | 6.24 | 35.2 |
| Total assets | 8.23 | 8.61 | 42.7 | |
| Accounts payable | 0.46 | 1.51 | 0.8 | |
| Accrued liabilities | 0.16 | 0.71 | 0.52 | |
| Deferred revenue | 0.06 | 0.15 | 1.44 | |
| Short-term debt | 0.68 | 0 | 1.52 | |
| Total current liabilities | 1.37 | 2.37 | 4.28 | |
| Long-term debt | 1.21 | 0 | 18.3 | |
| Total liabilities | 2.58 | 2.37 | 22.6 | |
| Total debt | 1.89 | 0 | 19.9 | |
| Paid-in capital | 0 | 6.5 | ||
| Retained earnings | 0 | 13.6 | ||
| Shareholders' equity | 6.3 | 5.66 | 6.24 | 20.1 |
| Total equity | 6.3 | 5.66 | 6.24 | 20.1 |
| Total liabilities and equity | 8.23 | 8.61 | 42.7 | |
| Shares outstanding | 0 | 2.82 |
Cash flow statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Net income | 14 | 7.73 | 3.77 | 14.8 |
| Depreciation and amortization | 1.35 | 1.47 | 0.04 | 0.3 |
| Stock-based compensation | 0 | 0 | 0.29 | |
| Change in receivables | -0.87 | 0.64 | 0.08 | -1.39 |
| Change in inventory | 0.04 | -0.02 | -0.34 | 0.04 |
| Cash from operations | 14.1 | 9.3 | 4.96 | 3.94 |
| Capital expenditures | -0.2 | -0.56 | -0.21 | -32 |
| Cash from investing | -0.2 | -0.56 | -0.21 | -19.1 |
| Debt issued | 0 | 0 | 20 | |
| Debt repaid | -3.08 | -0.7 | -1.93 | 0 |
| Dividends paid | 0 | 0 | -1.18 | |
| Cash from financing | -14.8 | -9.07 | -5.12 | 18.7 |
| Net change in cash | -0.95 | -0.33 | -0.36 | 3.51 |
| Free cash flow | 13.9 | 8.74 | 4.75 | -28 |
| Interest paid | 0.2 | 0.21 | 0.05 | 0 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | 111.1% | Operating income / revenue. |
| EBITDA margin | 113.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Net margin | 111.6% | Net income / revenue. |
| FCF margin | -212.0% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 29.8% | Cash from operations / revenue. |
| Return on equity (ROE) | 112.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 57.5% | Net income / average total assets. |
| Return on invested capital (ROIC) | 54.3% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Stock-based pay / revenue | 2.2% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 241.8% | Capital expenditures / revenue. |
| D&A / revenue | 2.3% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -15.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -18.5% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 283.6% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 1.0% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 287.2% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -1.3% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | 291.1% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 1.7% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 287.5% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -20.5% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -34.6% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -689.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 222.2% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 47.2% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 396.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Share count change, 1y | 0.7% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.70x | Current assets / current liabilities. |
| Quick ratio | 1.21x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.78x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.99x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 46.5% | Total debt / total assets. |
| Liabilities / assets | 53.0% | Total liabilities / total assets. |
| Net debt | $16.5M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 1.10x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | $3.0M | Current assets - current liabilities. |
| Tangible book value | $20.1M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.52x | Revenue / average total assets. |
| Fixed asset turnover | 0.64x | Revenue / average property, plant and equipment. |
| Receivables turnover | 11.6x | Revenue / average receivables. |
| Days sales outstanding | 31 days | 365 x average receivables / revenue. |
| FCF conversion | -190.0% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 811.2% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $5.27 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $4.72 | Revenue / diluted weighted shares. |
| FCF per share | -$10.02 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.41 | Cash from operations / diluted weighted shares. |
| Book value per share | $7.14 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $7.14 | Tangible book value / shares outstanding. |
| Cash per share | $1.19 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 8.0% | Dividends paid / net income, when net income is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $33.7M | Share price x shares outstanding. |
| Enterprise value | $50.2M | Market cap + total debt - cash - short-term investments. |
| P/E | 2.28x | Market cap / net income. Only when net income is positive. |
| P/S | 2.54x | Market cap / revenue. |
| P/B | 1.67x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.67x | Market cap / tangible book value, when positive. |
| P/OCF | 8.54x | Market cap / cash from operations, when positive. |
| EV/Sales | 3.79x | Enterprise value / revenue. |
| EV/EBIT | 3.42x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 3.35x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -83.3% | Free cash flow / market cap. |
| Earnings yield | 43.8% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 3.5% | Dividends paid over the period / market cap. |
| Shareholder yield | 3.5% | (Dividends paid + share buybacks) / market cap. |
What was Euroholdings Ltd.'s revenue in fiscal 2025?
Euroholdings Ltd. reported revenue of $13.2M for fiscal 2025, 15.4% lower than the year before.
Was Euroholdings Ltd. profitable in fiscal 2025?
Yes. Net income was $14.8M, a net margin of 111.6%.
How much free cash flow did Euroholdings Ltd. generate in fiscal 2025?
Cash from operations of $3.9M minus capital expenditures of $32.0M left free cash flow of -$28.0M.